Paul Choi

Stock Analyst at Goldman Sachs

(3.58)
# 864
Out of 5,042 analysts
111
Total ratings
52.11%
Success rate
6.27%
Average return

Stocks Rated by Paul Choi

Arvinas
Oct 15, 2025
Downgrades: Sell
Price Target: $8$6
Current: $9.21
Upside: -34.85%
Lantheus Holdings
Oct 8, 2025
Downgrades: Neutral
Price Target: $110$77
Current: $56.06
Upside: +37.35%
Edgewise Therapeutics
Sep 25, 2025
Initiates: Neutral
Price Target: $20
Current: $15.18
Upside: +31.75%
Exelixis
Sep 17, 2025
Initiates: Buy
Price Target: $47
Current: $38.72
Upside: +21.38%
Amarin Corporation
Jun 25, 2025
Maintains: Sell
Price Target: $7$12
Current: $19.72
Upside: -39.15%
UroGen Pharma
May 22, 2025
Maintains: Neutral
Price Target: $16$3
Current: $18.97
Upside: -84.19%
Gossamer Bio
May 16, 2025
Maintains: Buy
Price Target: $7$8
Current: $2.48
Upside: +222.58%
Phathom Pharmaceuticals
May 2, 2025
Maintains: Neutral
Price Target: $10$5
Current: $13.53
Upside: -63.05%
Xenon Pharmaceuticals
Apr 17, 2025
Maintains: Buy
Price Target: $60$52
Current: $40.76
Upside: +27.58%
Vir Biotechnology
Apr 17, 2025
Maintains: Buy
Price Target: $28$21
Current: $5.98
Upside: +251.17%
Maintains: Neutral
Price Target: $14$12
Current: $13.03
Upside: -7.90%
Maintains: Neutral
Price Target: $4$3
Current: $2.71
Upside: +10.70%
Maintains: Sell
Price Target: $12$10
Current: $10.38
Upside: -3.66%
Maintains: Buy
Price Target: $200$225
Current: $202.00
Upside: +11.39%
Maintains: Sell
Price Target: $32$42
Current: $66.40
Upside: -36.75%
Downgrades: Neutral
Price Target: $85$60
Current: $57.83
Upside: +3.75%
Maintains: Neutral
Price Target: $17$19
Current: $14.70
Upside: +29.25%
Maintains: Buy
Price Target: $22$32
Current: $38.93
Upside: -17.80%
Maintains: Buy
Price Target: $29$50
Current: $54.26
Upside: -7.85%
Maintains: Buy
Price Target: $21$19
Current: $4.07
Upside: +366.83%
Maintains: Sell
Price Target: $400$50
Current: $10.83
Upside: +361.68%
Maintains: Buy
Price Target: $43$25
Current: $1.56
Upside: +1,502.56%
Maintains: Buy
Price Target: $151$170
Current: $16.60
Upside: +924.10%
Maintains: Sell
Price Target: $9$8
Current: $5.23
Upside: +52.96%
Downgrades: Neutral
Price Target: $135
Current: $144.00
Upside: -6.25%
Upgrades: Neutral
Price Target: $270$300
Current: $60.10
Upside: +399.17%